Arbutus Biopharma Corporation (Nasdaq: ABUS) recently presented compelling data on its investigational hepatitis B therapies, ...

Viral hepatitis is a leading cause of liver disease, liver cancer and liver transplant in the United States and is a focus of an annual national awareness campaign that occurs ...

Vir Bio (VIR) reveals 24-week post-end-of-treatment data from a mid-stage trial for its Hep B therapy developed with Xencor ...

Hepatitis is an inflammation of the liver, most commonly caused by a viral infection. The three main types—Hepatitis A, B, ...

Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the lower limit of detection (LLOD), is associated with better clinical ...

Hepatitis B is a highly infectious liver disease caused by the Hepatitis B virus (HBV) and is primarily transmitted through infected blood, bodily fluids, or childbirth. Although many cases are acute ...

BPD announced at 2:42 p.m. that the road has been reopened. Original coverage: April 21 at 12:42 p.m. BILLINGS, Mont. – A structure fire in the 3900 block of Olympic has led to road closures in the ...

HDV was discovered in patients infected with hepatitis B virus (HBV). It generally makes ... 74% base pairing to form an unbranched rod-like structure. The genome sequence shows no homology ...

Lab scientists at the Centers for Disease Control and Prevention had been analyzing blood samples for weeks to determine how dozens of patients across six states had become infected with viral ...

the key source of replicating hepatitis B virus (HBV), and inactivating integrated HBV DNA in hepatocytes. “We are pleased to receive Fast Track designation from the FDA for PBGENE-HBV and ...